Praj Industries Ltd

Q4 FY26 Earnings Call Analysis

Industrial Manufacturing

Full Stock Analysis
revenue: Category 2margin: Category 3orderbook: Yesfundraise: No informationcapex: Yes
💰

fundraise

Any current/future new fundraising through debt or equity?

- There is no explicit mention of any current or planned new fundraising through debt or equity in the provided transcript sections. - The company discussed investments in facilities (e.g., GenX plant at Mangalore) and operating expenses but did not reference raising capital through equity or debt issuance. - Cash in hand as of December 31 is Rs. 6.4 billion, indicating available liquidity. - The discussion indicates focus on revenue growth and margin improvement rather than new fundraising. - No direct comments were made regarding plans for debt or equity fundraising in near future during the Q&A or management commentary.
🏗️

capex

Any current/future capex/capital investment/strategic investment?

- Formation of JV between Praj and BPCL approved by respective boards to set up CBG plants across India. Capital commitment and structure to be finalized based on number of projects; detailed work ongoing (Page 10). - Mangalore engineering facility fully ready with over Rs. 200 crores invested in CAPEX and about Rs. 80 crores in operating expenses YTD. Delays in land acquisition impacted current year activity; revenues expected from H2 FY26 (Page 4). - Future capital investments linked to JV projects, SAF plants, international expansion, and technology innovations in zero liquid discharge and bioplastics (Pages 4, 22). - Strategic investments focus on entering new markets (internationalization target 50% revenue by 2030), technology leadership in bioenergy, SAF, and CBG ecosystems (Pages 4, 6, 22). - Capital investment amounts for JV and other projects will be clearer after project finalization expected within the next 3-4 months (Page 10).
📊

revenue

Future growth expectations in sales/revenue/volumes?

- Targeting 3x revenue growth by 2030, aiming for Rs. 10,000 crores topline. - International revenue expected to grow 8x from Rs. 665 crores in FY24 to approx. Rs. 5,000 crores by FY30. - Goal to achieve a 50:50 revenue split between domestic and international markets by FY30. - Growth driven by GenX products, bioenergy (bio-ethanol and biofuels), and Clean Process Engineering Solutions (CPES). - Bioenergy business, including international biofuel projects in Brazil and Tanzania, expected to expand significantly. - Adoption and development of SAF (Sustainable Aviation Fuel) and ATJ (Alcohol to Jet) routes to augment revenue streams. - CBG (Compressed Bio-Gas) segment at a nascent stage but poised for increased traction with multiple projects under construction. - Domestic market growth supported by blending mandates (e.g., 20% ethanol blending target). - Bio-bitumen and fertilizer by-products present future growth opportunities.
📈

margin

Future growth expectations in earnings/operating earnings/profits/EPS?

- Praj Industries targets 3x revenue growth and 5x bottom-line growth by FY30 (Page 13). - The company aims for a 50%-50% revenue split between domestic and international markets by FY30, with international growth expected to outpace domestic (Page 6). - Margin performance depends on product mix; expected positive margin trends over time despite short-term dips (Page 11). - Bioenergy business, including SAF and bio-ethanol, is a key driver for growth and improved margins, especially from international markets (Pages 19-20). - Expenses related to GenX facility expected to moderate as revenues from this facility increase in coming years (Pages 8-9). - Execution delays affect short-term revenue but expected to normalize from FY26, leading to stronger earnings (Page 11). - Overall, Praj remains confident of delivering on guidance with strong order backlog and expanding international footprint (Pages 3, 6).
📋

orderbook

Current/ Expected Orderbook/ Pending Orders?

- Order backlog as of December 24th stands at Rs. 43.5 billion. - 75% of the order backlog is from the domestic market. - Order intake during Q3 FY25 was Rs. 10.5 billion. - 60% of the quarterly order intake came from the domestic market. - 77% of the order intake is from bioenergy, 17% from engineering, and 6% from PHS business. - Share of international order book in the last three quarters has grown to 40%. - The order book is the highest seen over the last three quarters, reflecting growing traction. - There is a known pipeline of inquiries for larger projects, particularly with the new GenX facility coming online, signaling expected future order growth.